Paolo Chieffi
Naples, Italy
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 58 publications
Potential therapeutic targets and biomarkers in testicular germ cell tumor oncogenesis.
Journal: Expert opinion on therapeutic targets
Published: August 21, 2025
Modulation of NCX1 expression in monocytes associates with multiple sclerosis progression.
Journal: Heliyon
Published: May 17, 2024
Drug-induced inhibition of HMGA and EZH2 activity as a possible therapy for anaplastic thyroid carcinoma.
Journal: Cell cycle (Georgetown, Tex.)
Published: January 02, 2024
Testicular/paratesticular mesothelial tumours: Uncommon histopathologic entities in a very complex anatomical site.
Journal: Pathology, research and practice
Published: November 27, 2023
The role of endocrine gland derived vascular growth factor/ Prokineticin-1 in human prostate cells.
Journal: GHM open
Published: November 01, 2023
Analysis of microsatellite instability (MSI) in pediatric gonadal and extra-gonadal germ cell tumors.
Journal: Intractable & rare diseases research
Published: May 16, 2023
The lncRNA RMST is drastically downregulated in anaplastic thyroid carcinomas where exerts a tumor suppressor activity impairing epithelial-mesenchymal transition and stemness.
Journal: Cell death discovery
Published: March 28, 2023
The role of HMGA1 protein in gastroenteropancreatic neuroendocrine tumors.
Journal: Cell cycle (Georgetown, Tex.)
Published: March 14, 2022
GPR30: A new potential therapeutic target in human testicular germ cell tumors.
Journal: Intractable & rare diseases research
Published: July 14, 2021
Publisher Correction: HMGA1-pseudogene7 transgenic mice develop B cell lymphomas.
Journal: Scientific reports
Published: June 12, 2021
Last Updated: 09/26/2026